Literature DB >> 18379443

Letter to the editor: oral lichenoid disease. A new classification proposal.

José M Aguirre Urizar.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18379443

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN： 1698-4447


× No keyword cloud information.
  6 in total

1.  Oral lichenoid lesions associated with amalgam restorations: a prospective pilot study addressing the adult population of the Basque Country.

Authors:  M-J Lartitegui-Sebastián; B Martínez-Revilla; C Saiz-Garcia; S Eguizabal-Saracho; J-M Aguirre-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-07-01

2.  TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease.

Authors:  Peter Rusanen; Emilia Marttila; Johanna Uittamo; Jaana Hagström; Tuula Salo; Riina Rautemaa-Richardson
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

3.  Histopathological characterization of the oral lichenoid disease subtypes and the relation with the clinical data.

Authors:  J Alberdi-Navarro; X Marichalar-Mendia; M-J Lartitegui-Sebastián; M-L Gainza-Cirauqui; M-A Echebarria-Goikouria; J-M Aguirre-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

4.  Prevalence of oral mucosal normal variations and lesions in a middle-aged population: a Northern Finland Birth Cohort 1966 study.

Authors:  Ulla-Maija Oivio; Paula Pesonen; Merja Ylipalosaari; Arja Kullaa; Tuula Salo
Journal:  BMC Oral Health       Date:  2020-12-09       Impact factor: 2.757

5.  Epidermal growth factor receptor expression in different subtypes of oral lichenoid disease.

Authors:  Dionisio-Alejandro Cortés-Ramírez; María-Jose Rodríguez-Tojo; Juan-Carlos Coca-Meneses; Xabier Marichalar-Mendia; José-Manuel Aguirre-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-09-01

6.  Clinical Study of Oral Mucosal Lesions in the Elderly-Prevalence and Distribution.

Authors:  Małgorzata Radwan-Oczko; Kinga Bandosz; Zofia Rojek; Joanna E Owczarek-Drabińska
Journal:  Int J Environ Res Public Health       Date:  2022-03-01       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.